FDA Awards Priority Review Voucher to Sponsor of Rare Pediatric Disease Product ZYNTEGLO

Summary

The FDA has issued a priority review voucher to bluebird bio, Inc., the manufacturer of ZYNTEGLO, a rare pediatric disease product, following a review of the product's eligibility under the Federal Food, Drug, and Cosmetic Act.